Skip to main content
. 2018 Jul-Sep;7(3):188–192. doi: 10.4103/sajc.sajc_87_18

Table 2.

Overall tumor response in patients treated with nimotuzumab and standard treatment (n=12)

graphic file with name SAJC-7-188-g003.jpg